trial · primary record
Testosterone Cypionate 75 mg
Male Hypogonadism
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 190 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Percentage of Participants With Average Serum Total Testosterone Concentration Within 300-1100 ng/dL at Week 12 |
| Registry ID | NCT07898072 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:46.854Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07898072
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.